Cliff Asness's EXAS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.82 M shares of Exact Sciences Corporation (EXAS) worth $97.49 M, representing 0.06% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in EXAS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 741,517 shares. Largest reduction occurred in Q3 2013, reducing 576,000 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2012 | +64,708 | Add 0.00% | 64,707 | $10.59 |
| Q2 2013 | +587,608 | Add 0.00% | 587,607 | $13.91 |
| Q3 2013 | -576,000 | Reduce 98.02% | 11,607 | $11.80 |
| Q4 2013 | -11,607 | Sold Out | 11,607 | $0.00 |
| Q3 2014 | +43,107 | New Buy | 43,107 | $19.37 |
| Q4 2014 | +22,700 | Add 52.66% | 65,807 | $27.44 |
| Q2 2015 | +4,042 | Add 6.14% | 69,849 | $29.74 |
| Q3 2015 | -20,493 | Reduce 29.34% | 49,356 | $17.99 |
| Q4 2015 | -49,356 | Sold Out | 49,356 | $0.00 |
| Q3 2016 | +130,036 | New Buy | 130,036 | $18.56 |
| Q4 2016 | +2,760 | Add 2.12% | 132,796 | $13.36 |
| Q1 2017 | +86,315 | Add 65.00% | 219,111 | $23.62 |
| Q2 2017 | +711 | Add 0.32% | 219,822 | $35.37 |
| Q3 2017 | -6,269 | Reduce 2.85% | 213,553 | $47.12 |
| Q4 2017 | -14,216 | Reduce 6.66% | 199,337 | $52.54 |
| Q1 2018 | +6,406 | Add 3.21% | 205,743 | $40.33 |
| Q2 2018 | -149,906 | Reduce 72.86% | 55,837 | $59.78 |
| Q3 2018 | -28,224 | Reduce 50.55% | 27,613 | $78.91 |
| Q4 2018 | -11,725 | Reduce 42.46% | 15,888 | $63.13 |
| Q1 2019 | +45,118 | Add 283.98% | 61,006 | $86.61 |
| Q2 2019 | -37,274 | Reduce 61.10% | 23,732 | $118.03 |
| Q3 2019 | +728 | Add 3.07% | 24,460 | $90.35 |
| Q4 2019 | -8,492 | Reduce 34.72% | 15,968 | $92.31 |
| Q1 2020 | -1,559 | Reduce 9.76% | 14,409 | $58.02 |
| Q2 2020 | -9,193 | Reduce 63.80% | 5,216 | $85.51 |
| Q3 2020 | -1,706 | Reduce 32.71% | 3,510 | $101.71 |
| Q4 2020 | +7,965 | Add 226.92% | 11,475 | $132.46 |
| Q1 2021 | +2,198 | Add 19.15% | 13,673 | $128.36 |
| Q2 2021 | -9,666 | Reduce 70.69% | 4,007 | $124.28 |
| Q4 2021 | -4,007 | Sold Out | 4,007 | $0.00 |
| Q1 2023 | +5,348 | New Buy | 5,348 | $66.50 |
| Q2 2023 | +115,346 | Add 2156.81% | 120,694 | $93.90 |
| Q3 2023 | +207,623 | Add 172.02% | 328,317 | $68.22 |
| Q4 2023 | +313,110 | Add 95.37% | 641,427 | $73.98 |
| Q1 2024 | -88,271 | Reduce 13.76% | 553,156 | $69.06 |
| Q2 2024 | -399,558 | Reduce 72.23% | 153,598 | $42.25 |
| Q3 2024 | +101,060 | Add 65.80% | 254,658 | $66.55 |
| Q4 2024 | +337,727 | Add 132.62% | 592,385 | $56.19 |
| Q1 2025 | +419,381 | Add 70.80% | 1.01 M | $43.14 |
| Q2 2025 | +741,517 | Add 73.29% | 1.75 M | $53.14 |
| Q3 2025 | +63,894 | Add 3.64% | 1.82 M | $53.65 |
Cliff Asness's Exact Sciences Corporation Investment FAQs
Cliff Asness first purchased Exact Sciences Corporation (EXAS) in Q4 2012, acquiring 64,707 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Exact Sciences Corporation (EXAS) for 52 quarters since Q4 2012. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Exact Sciences Corporation (EXAS) was in Q2 2025, adding 1,753,283 shares worth $93.17 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,817,177 shares of Exact Sciences Corporation (EXAS), valued at approximately $97.49 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.06% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Exact Sciences Corporation (EXAS) was 1,817,177 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.